RVMD
Price
$81.19
Change
+$0.92 (+1.15%)
Updated
Dec 24 closing price
Capitalization
15.7B
67 days until earnings call
Intraday BUY SELL Signals
VRDN
Price
$32.28
Change
+$0.17 (+0.53%)
Updated
Dec 24 closing price
Capitalization
3.08B
70 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RVMD vs VRDN

Header iconRVMD vs VRDN Comparison
Open Charts RVMD vs VRDNBanner chart's image
Revolution Medicines
Price$81.19
Change+$0.92 (+1.15%)
Volume$1.4M
Capitalization15.7B
Viridian Therapeutics
Price$32.28
Change+$0.17 (+0.53%)
Volume$403.58K
Capitalization3.08B
RVMD vs VRDN Comparison Chart in %
RVMD
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RVMD vs. VRDN commentary
Dec 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVMD is a Hold and VRDN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 25, 2025
Stock price -- (RVMD: $81.19 vs. VRDN: $32.28)
Brand notoriety: RVMD and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVMD: 58% vs. VRDN: 22%
Market capitalization -- RVMD: $15.7B vs. VRDN: $3.08B
RVMD [@Biotechnology] is valued at $15.7B. VRDN’s [@Biotechnology] market capitalization is $3.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVMD’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • RVMD’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, RVMD is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVMD’s TA Score shows that 3 TA indicator(s) are bullish while VRDN’s TA Score has 3 bullish TA indicator(s).

  • RVMD’s TA Score: 3 bullish, 4 bearish.
  • VRDN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RVMD is a better buy in the short-term than VRDN.

Price Growth

RVMD (@Biotechnology) experienced а +5.80% price change this week, while VRDN (@Biotechnology) price change was +0.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

RVMD is expected to report earnings on Mar 02, 2026.

VRDN is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($15.7B) has a higher market cap than VRDN($3.08B). RVMD YTD gains are higher at: 85.620 vs. VRDN (68.388). VRDN has higher annual earnings (EBITDA): -298.48M vs. RVMD (-1.02B). RVMD has more cash in the bank: 1.93B vs. VRDN (491M). VRDN has less debt than RVMD: VRDN (21.6M) vs RVMD (158M). VRDN has higher revenues than RVMD: VRDN (70.8M) vs RVMD (0).
RVMDVRDNRVMD / VRDN
Capitalization15.7B3.08B510%
EBITDA-1.02B-298.48M343%
Gain YTD85.62068.388125%
P/E RatioN/AN/A-
Revenue070.8M-
Total Cash1.93B491M393%
Total Debt158M21.6M731%
FUNDAMENTALS RATINGS
RVMD vs VRDN: Fundamental Ratings
RVMD
VRDN
OUTLOOK RATING
1..100
8876
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
4862
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
3637
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VRDN's Valuation (52) in the Biotechnology industry is somewhat better than the same rating for RVMD (96) in the null industry. This means that VRDN’s stock grew somewhat faster than RVMD’s over the last 12 months.

RVMD's Profit vs Risk Rating (48) in the null industry is in the same range as VRDN (62) in the Biotechnology industry. This means that RVMD’s stock grew similarly to VRDN’s over the last 12 months.

RVMD's SMR Rating (97) in the null industry is in the same range as VRDN (98) in the Biotechnology industry. This means that RVMD’s stock grew similarly to VRDN’s over the last 12 months.

RVMD's Price Growth Rating (36) in the null industry is in the same range as VRDN (37) in the Biotechnology industry. This means that RVMD’s stock grew similarly to VRDN’s over the last 12 months.

RVMD's P/E Growth Rating (100) in the null industry is in the same range as VRDN (100) in the Biotechnology industry. This means that RVMD’s stock grew similarly to VRDN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RVMDVRDN
RSI
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
75%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
RVMD
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VVILX28.460.09
+0.32%
Vulcan Value Partners Institutional
PGRCX46.880.09
+0.19%
BNY Mellon Worldwide Growth C
QUAYX79.970.09
+0.11%
AB Small Cap Growth Advisor
FNIAX46.43N/A
N/A
Fidelity Advisor New Insights A
GGSOX16.29N/A
N/A
Grandeur Peak Global Stalwarts Investor

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with NUVL. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+1.15%
NUVL - RVMD
61%
Loosely correlated
+0.89%
CGON - RVMD
55%
Loosely correlated
+0.22%
CLDX - RVMD
54%
Loosely correlated
+0.94%
IDYA - RVMD
54%
Loosely correlated
+0.76%
IRON - RVMD
52%
Loosely correlated
+0.76%
More

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with NUVL. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
+0.53%
NUVL - VRDN
58%
Loosely correlated
+0.89%
XNCR - VRDN
56%
Loosely correlated
-0.13%
CLDX - VRDN
54%
Loosely correlated
+0.94%
SYRE - VRDN
54%
Loosely correlated
-0.54%
RVMD - VRDN
51%
Loosely correlated
+1.15%
More